Related references
Note: Only part of the references are listed.An Atypical Case of IgG4-Related Sclerosing Pancreatitis on PET/CT Imaging
Lei Han et al.
CLINICAL NUCLEAR MEDICINE (2014)
Use of Diffusion-Weighted MRI to Differentiate Chronic Pancreatitis From Pancreatic Cancer
Kumaresan Sandrasegaran et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT
Shigeki Nagamachi et al.
ANNALS OF NUCLEAR MEDICINE (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Limited Efficacy of 18F-FDG PET/CT for Differentiation Between Metastasis-Free Pancreatic Cancer and Mass-Forming Pancreatitis
Katsuhiko Kato et al.
CLINICAL NUCLEAR MEDICINE (2013)
Detection of Hypoxia With 18F-Fluoromisonidazole (18F-FMISO) PET/CT in Suspected or Proven Pancreatic Cancer
Tatiana Segard et al.
CLINICAL NUCLEAR MEDICINE (2013)
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
Daniel Putzer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Role of respiratory-gated PET/CT for pancreatic tumors: A preliminary result
Takeo Kasuya et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: Experience from tropics
Sampath Santhosh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT
Ron Epelbaum et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Role of SUVmax obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation
Si-Long Hu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
Aya Sugyo et al.
PLOS ONE (2013)
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Pathologic Response to Preoperative Chemoradiation Therapy in Patients With Resectable T3 Pancreatic Cancer
Hirotada Kittaka et al.
WORLD JOURNAL OF SURGERY (2013)
The incidences and mortalities of major cancers in China, 2009
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER (2013)
Yttrium-labelled peptides for therapy of NET
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Significance of Lymph Node Micrometastasis in Pancreatic Cancer Patients
J. Katuchova et al.
EUROPEAN SURGICAL RESEARCH (2012)
Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: A meta-analysis using a hierarchical regression model
Lian-Ming Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer
Jon K. Bjerregaard et al.
ACTA ONCOLOGICA (2011)
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
Erkan Topkan et al.
BMC GASTROENTEROLOGY (2011)
FDG PET/CT features of ovarian metastasis
K. Kitajima et al.
CLINICAL RADIOLOGY (2011)
Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
Shuang Tang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
18F-FDG PET/CT influences management in patients with known or suspected pancreatic cancer
T. W. Barber et al.
INTERNAL MEDICINE JOURNAL (2011)
18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT
Mitsuaki Tatsumi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: A prospective study
Nicolas C. Buchs et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
Manish Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations
Koji Murakami
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT
Yasunari Yamada et al.
ABDOMINAL IMAGING (2010)
Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer
Minsig Choi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Imaging Human Pancreatic Cancer Xenografts by Targeting Mutant KRAS2 mRNA with [111In]DOTAn-Poly(diamidopropanoyl)m-KRAS2 PNA-D(Cys-Ser-Lys-Cys) Nanoparticles
Nariman V. Amirkhanov et al.
BIOCONJUGATE CHEMISTRY (2010)
Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head
K. L. Prenzel et al.
EJSO (2010)
Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer
Hisashi Imai et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor Relapse after Pancreatic Cancer Resection is Detected Earlier by 18-FDG PET than by CT
Cosimo Sperti et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Performance of Integrated FDG-PET/Contrast-enhanced CT in the Diagnosis of Recurrent Pancreatic Cancer: Comparison with Integrated FDG-PET/Non-contrast-enhanced CT and Enhanced CT
Kazuhiro Kitajima et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic Cancer
Saila P. Kauhanen et al.
ANNALS OF SURGERY (2009)
Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung Cancer
Takayoshi Shinya et al.
CLINICAL NUCLEAR MEDICINE (2009)
The Clinical Usefulness of 18F-FDG PET/CT for the Evaluation of Lymph Node Metastasis in Periorbital Malignancies
Chung-Hwan Baek et al.
KOREAN JOURNAL OF RADIOLOGY (2009)
Mass-forming pancreatitis with positive fluoro-2-deoxy-d-glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a case
Masaaki Nishi et al.
SURGERY TODAY (2009)
Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity Results of a Prospective Phase II Trial
Stefan Heinrich et al.
ANNALS OF SURGERY (2008)
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms
Jeffrey M. Farma et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography
Yayoi Ozaki et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer
Corinna von Forstner et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Contrast-enhanced F-18-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer
Klaus Strobel et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors
Ken Herrmann et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas
Hiroki Sakamoto et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2008)
Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer
Hisao Wakabayashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
A. Quon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Autoimmune pancreatitis with multifocal lesions
Masatoshi Kajiwara et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Focal pancreatic mass: Distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI
Jai K. Kim et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
Surgical palliation in patients with pancreatic cancer
Joerg Koeninger et al.
LANGENBECKS ARCHIVES OF SURGERY (2007)
The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer
Seungmin Bang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
The role of positron emission tomography in the management of pancreatic cancer
Farrokh Pakzad et al.
SEMINARS IN NUCLEAR MEDICINE (2006)
Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer
Kosei Maemura et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2006)
Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis
Y Yokoyama et al.
PANCREAS (2005)
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
S Heinrich et al.
ANNALS OF SURGERY (2005)
FDG-PET in the detection of early pancreatic cancer in a BOP hamster model
MCA van Kouwen et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis
MCA van Kouwen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Detection of recurrent pancreatic cancer: Comparison of FDG-PET with CT/MRI
J Ruf et al.
PANCREATOLOGY (2005)
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer
D Lytras et al.
DIGESTIVE SURGERY (2005)
EURO-EUS 2003: Pancreatic tumor - Impact of endoscopic ultrasonography on diagnosis, staging and treatment
PG Arcidiacono et al.
CANCER BIOLOGY & THERAPY (2004)
Clinicopathological aspects of small pancreatic cancer
S Egawa et al.
PANCREAS (2004)
Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC)
G Henriksen et al.
NUCLEAR MEDICINE AND BIOLOGY (2004)
Role of positron emission tomography with 2-deoxy-2-[F-18]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer
M Yoshioka et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours
WW de Herder et al.
ENDOCRINE-RELATED CANCER (2003)
18-fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma
C Sperti et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2003)
Tuberculous lymphadenitis as a cause of obstructive jaundice: Report of a case
K Obama et al.
SURGERY TODAY (2003)
Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma
D Becker et al.
GASTROINTESTINAL ENDOSCOPY (2001)
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses
CG Diederichs et al.
PANCREAS (2000)
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma
HR Mertz et al.
GASTROINTESTINAL ENDOSCOPY (2000)
Share Paper
